MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
STRO Cash Flow Sankey Diagram
Sankey diagram visualizing STRO cash flow for the period
Maturities of marketable
securities
$32,026K
(-76.41%↓ Y/Y)
Sales of marketable
securities
$15,183K
(-33.42%↓ Y/Y)
Net cash used in
investing activities
$19,361K
(241.55%↑ Y/Y)
Canceled cashflow
$27,848K
Net decrease in
cash, cash...
-$19,347K
(84.68%↑ Y/Y)
Canceled cashflow
$19,361K
Non-cash interest
expense on deferred...
$9,862K
(-48.07%↓ Y/Y)
Accounts receivable
-$6,687K
(-983.79%↓ Y/Y)
Stock-based compensation
$2,010K
(-81.39%↓ Y/Y)
Depreciation and
amortization
$1,262K
(-66.79%↓ Y/Y)
Non-cash lease expenses
$1,240K
(-56.35%↓ Y/Y)
Accrued compensation
$831K
(172.83%↑ Y/Y)
Prepaid expenses and
other assets
-$382K
(94.05%↑ Y/Y)
Other
-$97K
(67.99%↑ Y/Y)
Proceeds from exercise of
common stock options
$50K
Purchases of marketable
securities
$27,848K
(-83.71%↓ Y/Y)
Net cash used in
operating activities
-$38,290K
(66.00%↑ Y/Y)
Canceled cashflow
$22,371K
Net cash provided by
financing activities
-$418K
(-7066.67%↓ Y/Y)
Canceled cashflow
$50K
Net loss
-$38,533K
(55.95%↑ Y/Y)
Accrued expenses and
other liabilities
-$12,965K
(-282.30%↓ Y/Y)
Deferred revenue
-$4,176K
(93.42%↑ Y/Y)
Operating lease liability
-$2,849K
(19.99%↑ Y/Y)
Accounts payable
-$1,685K
(70.57%↑ Y/Y)
Accretion of discount on
marketable securities
$453K
(-78.92%↓ Y/Y)
Proceeds from sales of
common stock, net of...
-$468K
Loss before
provision for income taxes
-$38,532K
Income tax benefits
(expense)
$1K
Revenue
$9,839K
Interest income
$1,723K
Loss from operations
-$29,888K
Non-operating loss
-$8,644K
Canceled cashflow
$9,839K
Canceled cashflow
$1,723K
Operating expenses
$39,727K
Non-cash interest
expense related to the...
$9,862K
Interest and other income
(expense), net
-$505K
Outside services
$17,194K
Personnel-related expenses
$12,776K
Equipment and
office-related expenses
$3,089K
Facility and maintenance
expenses
$2,934K
Preclinical research and
clinical development...
$2,651K
Laboratory supplies
$722K
Restructuring and related
costs
$201K
Travel-related expenses
$160K
Back
Back
SUTRO BIOPHARMA, INC. (STRO)
SUTRO BIOPHARMA, INC. (STRO)
Cash Flow
Quarterly Cash Flow Statement for the quarter ending in 2026-06-30
source: myfinsight.com